AbbVie stock rose after the drugmaker posted quarterly earnings early Wednesday that surpassed analysts’ expectations and increased its quarterly dividend. AbbVie also increased its dividend by 5.8% to $1.64 per share. “Based upon the momentum of AbbVie’s business and our confidence in the long-term growth outlook, we are once again raising our full-year guidance and are increasing our quarterly dividend,” CEO Rob Michael said.